Priya Kos
Adult Health · Raleigh, NCNPI 1851373229
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,988 of the $9,930 with a category attached, or 80.4%. Boston Scientific accounts for 68.5% of it on its own, with 21 other manufacturers making up the rest. Among adult health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $50.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- Johnson & Johnson$363
- Amgen$336
- E.r. Squibb & Sons, L.L.C.$281
- Esperion Therapeutics, Inc.$269
- AstraZeneca$251
- plus $2K from 16 others
What the payments were for
- Travel & lodging$1,94220%
- Food & beverage$7,98880%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 102 | $6,802 |
| Johnson & Johnson | 13 | $363 |
| Amgen | 12 | $336 |
| E.r. Squibb & Sons, L.L.C. | 12 | $281 |
| Esperion Therapeutics, Inc. | 3 | $269 |
| AstraZeneca | 5 | $251 |
| Actelion Pharmaceuticals US, Inc. | 5 | $211 |
| Abiomed | 2 | $197 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $188 |
| Alnylam Pharmaceuticals Inc. | 3 | $166 |
| Boehringer Ingelheim | 3 | $156 |
| Novartis | 8 | $150 |
| Novo Nordisk | 5 | $119 |
| Irhythm Technologies, Inc. | 3 | $86 |
| Medtronic | 1 | $76 |
| Pfizer | 4 | $65 |
| Abbott | 2 | $50 |
| Kestra Medical Technology Services, Inc. | 2 | $42 |
| Bristol Myers Squibb | 2 | $40 |
| Merck | 1 | $35 |
| Davol Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,930 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,140 | $1,104,764 |
| XareltoRivaroxaban | 158 | $153,881 |
| EntrestoSacubitril/Valsartan | 48 | $45,333 |
| Repatha SureclickEvolocumab | 38 | $42,267 |
| JardianceEmpagliflozin | 45 | $34,145 |
| Dofetilide | 150 | $27,985 |
| Flecainide Acetate | 341 | $12,373 |
| FarxigaDapagliflozin Propanediol | 15 | $11,152 |
| Metoprolol Succinate | 672 | $9,552 |
| BrilintaTicagrelor | 12 | $6,133 |
| Amiodarone Hcl | 265 | $4,700 |
| SotalolSotalol Hcl | 260 | $4,684 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 110 | $2,886 |
| Midodrine Hcl | 28 | $2,465 |
| Losartan Potassium | 178 | $2,409 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $1,104,7641,140 claims |
| Johnson & JohnsonXarelto | $363 | $153,881158 claims |
| NovartisEntresto | $150 | $45,33348 claims |
| Boehringer IngelheimJardiance | $156 | $34,14545 claims |
| AstraZenecaFarxiga, Brilinta | $251 | $17,28527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 adult health providers in North Carolina.
Other adult health in Raleigh
- Robert DodgeRaleigh$311K
- Henry VanpalaRaleigh$110K
- Patricia McGrailRaleigh$10K
- Alyssa KianiRaleigh$8K
- Katherine StahlRaleigh$5K
- Christopher EvansRaleigh$5K
- Kimberly CampDurham$147K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
- Anna BooneReidsville$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.